Athersys (NASDAQ:ATHX) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX) in a report released on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Stock Performance

Shares of NASDAQ:ATHX opened at $0.00 on Monday. Athersys has a 12 month low of $0.01 and a 12 month high of $1.99. The firm has a market cap of $203,672.70, a P/E ratio of 0.00 and a beta of -0.90.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.